Codes / ICD10CM / T53.3X1D

T53.3X1D Toxic effect of tetrachloroethylene, accidental (unintentional), subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of tetrachloroethylene, accidental (unintentional), subsequent encounter

Summary

This condition describes the adverse health effects resulting from accidental (unintentional) exposure to tetrachloroethylene, a volatile organic compound, during a subsequent encounter for care. The toxicity can affect multiple organ systems, particularly the central nervous system, liver, and kidneys, depending on the level and duration of exposure. It encompasses acute or chronic poisoning from inhalation, ingestion, or dermal contact, with the "subsequent encounter" indicating ongoing care after the initial event.

Causes

Exposure to tetrachloroethylene occurs through inhalation of its vapors, ingestion of contaminated substances, or direct skin contact. Common sources include industrial solvents, dry cleaning agents, and degreasing compounds. Accidental spills, improper handling, or occupational exposure in manufacturing or chemical processing environments are typical pathways for unintentional exposure.

Risk Factors

  • Occupational exposure in industries using tetrachloroethylene (e.g., dry cleaning, metal degreasing, or chemical manufacturing).
  • Inadequate ventilation or protective equipment during handling.
  • Accidental ingestion of contaminated water or food.
  • Prolonged or high-dose exposure, especially without safety measures.

Symptoms

  • Dizziness, headache, or confusion.
  • Nausea, vomiting, or abdominal pain.
  • Liver dysfunction (e.g., elevated enzymes, jaundice).
  • Kidney impairment (e.g., reduced urine output, electrolyte imbalances).
  • Respiratory irritation or difficulty breathing with high-level exposure.
  • Skin irritation or chemical burns from direct contact.

Diagnosis

Diagnosis involves a thorough patient history to identify potential exposure to tetrachloroethylene, including occupational or environmental details. Clinical evaluation assesses symptoms and organ function, with laboratory tests (e.g., liver and kidney function, blood tests) to detect toxicity. Imaging or additional tests may be used to evaluate organ damage. Confirmation often relies on correlating exposure history with clinical findings.

Treatment Options

Treatment focuses on removing the patient from the source of exposure and providing supportive care. This may include oxygen therapy for respiratory symptoms, intravenous fluids for dehydration, and medications to manage nausea or pain. In severe cases, specific antidotes or interventions to support organ function (e.g., dialysis for kidney failure) may be necessary. Long-term monitoring addresses persistent or delayed effects.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and promptness of treatment. Mild cases often resolve with supportive care, while severe exposure may lead to lasting organ damage. Follow-up care is essential to monitor recovery, manage chronic symptoms, and address any long-term complications. Regular check-ups and organ function tests help track progress.

Complications

Potential complications include persistent neurological deficits, chronic liver or kidney disease, respiratory problems, or skin damage. Severe exposure may result in organ failure or long-term disability. Early intervention reduces the risk of permanent harm.

Lifestyle & Prevention

Prevention involves minimizing exposure through proper ventilation, use of personal protective equipment (e.g., gloves, respirators), and safe handling of tetrachloroethylene-containing products. Avoiding contaminated environments and ensuring proper storage of chemicals reduces risk. Education on safety protocols is critical for workers in high-exposure industries.

When to Seek Professional Help

Seek immediate medical attention if exposure to tetrachloroethylene is suspected, especially with symptoms like difficulty breathing, severe dizziness, or abdominal pain. Ongoing care is necessary for subsequent encounters to monitor recovery and address complications. Contact a healthcare provider for persistent symptoms or concerns about long-term effects.

Tips for Medical Coders

Document the accidental (unintentional) nature of the exposure and the subsequent encounter for care. Ensure clinical notes specify the timing of the encounter relative to the initial toxic event and any ongoing treatment or monitoring. Code T53.3X1D is appropriate when the encounter occurs after the acute phase of toxicity and focuses on follow-up or management of residual effects.

Book a walkthrough

T53.3X1D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.